Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis

202358 citationsReviewbronze Open Access

Authors

Jeayoung Park · University of Maryland, Baltimore

Spyridon Ntelis · University of Maryland, Baltimore

Elvina Yunasan · University of Maryland, Baltimore

Katherine Downton · University of Maryland, Baltimore

Terry Cheuk‐Fung Yip · Chinese University of Hong Kong

Kashif M. Munir · University of Maryland, Baltimore

Nowreen Haq

Abstract

Our meta-analysis supports therapeutic benefits of liraglutide for patients with T1DM mainly for weight loss and insulin dose reduction. Newly diagnosed or C-pos patients do not appear to experience greater weight loss benefits.

Topics & Keywords

Diabetes Treatment and Management Diabetes Management and Research Pancreatic function and diabetes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Clinical Endocrinology & Metabolism

Volume 109, Issue 1, pp. 279-292

DOI: 10.1210/clinem/dgad471

Field-Weighted Citation Impact: 11.86